SC 13G/A | 2024-02-08 | Beryl Capital Management LLC | Zynerba Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
SC 13G | 2023-09-05 | Beryl Capital Management LLC | Zynerba Pharmaceuticals, Inc. | 4,426,381 | 8.2% | EDGAR |
SC 13D | 2023-08-24 | Harmony Biosciences Holdings, Inc. | Zynerba Pharmaceuticals, Inc. | 7,592,498 | 13.1% | EDGAR |
SC 13G/A | 2022-02-14 | ETF MANAGERS GROUP, LLC | Zynerba Pharmaceuticals, Inc. | 3,526,304 | 8.6% | EDGAR |
SC 13G/A | 2021-06-01 | ETF MANAGERS GROUP, LLC | Zynerba Pharmaceuticals, Inc. | 4,613,332 | 11.2% | EDGAR |
SC 13G/A | 2021-05-11 | ETF MANAGERS GROUP, LLC | Zynerba Pharmaceuticals, Inc. | 2,208,784 | 5.4% | EDGAR |
SC 13G/A | 2021-03-11 | ETF MANAGERS GROUP, LLC | Zynerba Pharmaceuticals, Inc. | 1,910,194 | 4.6% | EDGAR |
SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | Zynerba Pharmaceuticals, Inc. | 1,035,402 | 3.5% | EDGAR |
SC 13G/A | 2021-02-08 | RAPP MICHAEL | Zynerba Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2021-01-08 | ETF MANAGERS GROUP, LLC | Zynerba Pharmaceuticals, Inc. | 2,000,588 | 6.8% | EDGAR |
SC 13G/A | 2020-11-16 | ETF MANAGERS GROUP, LLC | Zynerba Pharmaceuticals, Inc. | 1,579,161 | 5.4% | EDGAR |
SC 13G/A | 2020-07-10 | BlackRock Inc. | Zynerba Pharmaceuticals, Inc. | 438,643 | 1.8% | EDGAR |
SC 13G/A | 2020-05-11 | ETF MANAGERS GROUP, LLC | Zynerba Pharmaceuticals, Inc. | 1,208,126 | 4.8% | EDGAR |
SC 13G | 2020-02-11 | VANGUARD GROUP INC | Zynerba Pharmaceuticals, Inc. | 1,673,962 | 7.2% | EDGAR |
SC 13G | 2020-02-07 | BlackRock Inc. | Zynerba Pharmaceuticals, Inc. | 1,513,605 | 6.5% | EDGAR |
SC 13G/A | 2019-12-02 | ETF MANAGERS GROUP, LLC | Zynerba Pharmaceuticals, Inc. | 2,683,403 | 8.3% | EDGAR |
SC 13G | 2019-06-04 | ETF MANAGERS GROUP, LLC | Zynerba Pharmaceuticals, Inc. | 2,223,773 | 10.6% | EDGAR |
SC 13G/A | 2019-01-29 | GENESIS CAPITAL ADVISORS LLC | Zynerba Pharmaceuticals, Inc. | 797,477 | 4.5% | EDGAR |
SC 13G/A | 2019-01-15 | RAPP MICHAEL | Zynerba Pharmaceuticals, Inc. | 1,490,000 | 8.4% | EDGAR |
SC 13G/A | 2018-02-14 | Cormorant Asset Management, LLC | Zynerba Pharmaceuticals, Inc. | 0 | - | EDGAR |